MEDICINAL CHEMISTRY

7 minute read

Jan. 30, 2024

Olutasidenib: Potentially Longer Complete Remissions in AML with a Second-Generation IDH1 Inhibitor

Author:

Shaima Qunies

Editor:

Rory McAtee

Other articles you may be interested in